Gensource Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.31 M
as on 02-07-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 741.43%
(FY 2022)
- Profit 231.32%
(FY 2022)
- Ebitda 84.90%
(FY 2022)
- Net Worth 4.40%
(FY 2022)
- Total Assets 6.55%
(FY 2022)
About Gensource Pharma Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.31 M, as per Ministry of Corporate Affairs (MCA) records.
Mallemputi Chowdary and Kavuru Kumar serve as directors at the Company.
- CIN/LLPIN
U24297TG2010PTC067165
- Company No.
067165
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gensource Pharma Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mallemputi Chowdary  | Director | 08-Feb-2017 | Current |
| Kavuru Kumar | Director | 23-Feb-2010 | Current |
Financial Performance and Corporate Structure Insights of Gensource Pharma Solutions.
Gensource Pharma Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 741.43% increase. The company also saw a substantial improvement in profitability, with a 231.32% increase in profit. The company's net worth moved up by a moderate rise of 4.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gensource Pharma Solutions?
In 2022, Gensource Pharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cronus Research Labs Private LimitedActive 10 years 1 monthMallemputi Chowdary and Kavuru Kumar are mutual person
Cronus Pharma Specialities India Private LimitedActive 9 years 3 monthsMallemputi Chowdary and Kavuru Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gensource Pharma Solutions?
Gensource Pharma Solutions has a workforce of 10 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gensource Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gensource Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
